A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities (Q35607159)

9 August 2017

1 reference

MDMA

0 references

title

A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities (English)

1 reference

9 August 2017

Fabrizio Schifano

1

1 reference

9 August 2017

publication date

13 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

173

1 reference

9 August 2017

issue

3-4

1 reference

9 August 2017

page(s)

242-248

1 reference

MDMA: A Review of Epidemiological Data

9 August 2017

cites work

1 reference

12 December 2020

CYP2D6 deficiency, a factor in ecstasy related deaths?

1 reference

12 December 2020

Ecstasy and neurodegeneration. Advice is that "less is more".

1 reference

12 December 2020

Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine

1 reference

12 December 2020

Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.

1 reference

12 December 2020

"Saturday night fever": ecstasy related problems in a London accident and emergency department

1 reference

12 December 2020

Serotonin syndrome and other serotonergic disorders

1 reference

12 December 2020

Accidental ingestion of Ecstasy by a toddler: unusual cause for convulsion in a febrile child

1 reference

12 December 2020

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

12 December 2020

A new method to monitor drugs at dance venues

1 reference

12 December 2020

The serotonin syndrome and its treatment

1 reference

12 December 2020

[Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning]

1 reference

12 December 2020

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

1 reference

12 December 2020

Death following ingestion of MDMA (ecstasy) and moclobemide

1 reference

12 December 2020

The content of ecstasy tablets: implications for the study of their long-term effects.

1 reference

12 December 2020

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

1 reference

12 December 2020

The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus

1 reference

12 December 2020

Chemistry and pharmacology of hallucinogens, entactogens and stimulants

1 reference

12 December 2020

Ecstasy pill testing: harm minimization gone too far?

1 reference

12 December 2020

3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

1 reference

12 December 2020

Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.

1 reference

12 December 2020

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

12 December 2020

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

12 December 2020

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

12 December 2020

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

1 reference

12 December 2020

4-MTA: a new synthetic drug on the dance scene.

1 reference

12 December 2020

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

1 reference

12 December 2020

Fatal interaction between ritonavir and MDMA

1 reference

12 December 2020

Chemical analysis of ecstasy pills

1 reference

12 December 2020

Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project.

1 reference

12 December 2020

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

1 reference

12 December 2020

Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS

1 reference

12 December 2020

Recent paramethoxyamphetamine deaths

1 reference

12 December 2020

Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.

1 reference

12 December 2020

Review of deaths related to taking ecstasy, England and Wales, 1997-2000.

1 reference

12 December 2020

Pharmacology of MDMA in Humans

1 reference

12 December 2020

Ecstasy is low in league table of major causes of deaths

1 reference

12 December 2020

Hyponatraemia and death after "ecstasy" ingestion

1 reference

12 December 2020

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

12 December 2020

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

1 reference

12 December 2020

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

12 December 2020

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

1 reference

12 December 2020

Understanding the suicidal brain

1 reference

12 December 2020

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

1 reference

12 December 2020

Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000

1 reference

12 December 2020

Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

1 reference

12 December 2020

Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings

1 reference

12 December 2020

Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing

1 reference

12 December 2020

The use of drugs within the techno party scene in European metropolitan cities

1 reference

12 December 2020

Ecstasy (MDMA) deaths in New York City: a case series and review of the literature

1 reference

12 December 2020

Young woman dies of water intoxication after taking one tablet of ecstasy. Today's drug panorama calls for increased vigilance in health care

1 reference

12 December 2020

Fatal uncertainty: death-rate from use of ecstasy or heroin

1 reference

12 December 2020

Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release.

1 reference

12 December 2020

Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis

1 reference

12 December 2020

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

12 December 2020

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

1 reference

12 December 2020

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

12 December 2020

[Grand mal series after Ecstasy abuse]

1 reference

12 December 2020

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

1 reference

12 December 2020

Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?

1 reference

12 December 2020

10.1007/S00213-003-1730-5

Identifiers

DOI

1 reference

9 August 2017

1 reference